Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COLGATE PALMOLIVE CO Director's Dealing 2023

Sep 13, 2023

29956_dirs_2023-09-13_459ae6c4-0b74-4f88-8137-f3c2b1fdfefc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLGATE PALMOLIVE CO (CL)
CIK: 0000021665
Period of Report: 2023-09-11

Reporting Person: Wallace Noel R. (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-09-11 Common Stock M 48627.0000 $73.0000 Acquired 295596.0000 Direct
2023-09-11 Common Stock S 48627.0000 $73.3745 Disposed 246969.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-09-11 Stock Option (Right to Buy) $73.0000 M 48627.0000 Disposed 2023-09-25 Common Stock (48627.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 51058.0000 Indirect
Common Stock 52000.0000 Indirect
Common Stock 335.0000 Indirect

Footnotes

F1: Exercise of stock options awarded under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 16, 2023.

F2: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 16, 2023.

F3: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $73.20 to $73.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.